Mode
Text Size
Log in / Sign up

Immune-epigenetic-metabolic crosstalk drives immune evasion and promotes disease progression in endometriosisImmune and Metabolic Changes Linked to Endometriosis Progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that immune-epigenetic-metabolic crosstalk facilitates immune evasion in patients with endometriosis.

This systematic review explores the complex interplay between immune, epigenetic, and metabolic pathways in the pathogenesis of endometriosis. The synthesis focuses on how these three domains converge to facilitate disease progression and clinical resistance.

Key findings indicate that the local environment promotes immune evasion through reduced cytotoxic activity and functional exhaustion of effector cells, alongside the expansion of immunosuppressive cells and overexpression of checkpoint molecules. These processes are supported by epigenetic remodeling, where DNA methylation, histone modifications, and non-coding RNAs silence pro-inflammatory genes to maintain immune cell tolerance.

Furthermore, metabolic reprogramming is identified as a critical driver; specifically, hypoxia stimulates glycolysis and lactate accumulation. These metabolites act as signaling molecules or cofactors for enzymes that facilitate the observed epigenetic changes. While the review identifies these mechanisms as potential targets for future multi-pronged therapies, it does not provide clinical trial data or specific drug efficacy results.

How this fits prior evidence

This systematic review addresses a gap in understanding the underlying molecular mechanisms of endometriosis by detailing how metabolic and epigenetic factors contribute to immune evasion. It extends the scope of existing knowledge regarding gynecological disease pathology beyond simple anatomical or symptomatic observations, potentially offering new targets for future interventions.

Researchers have identified a complex link between the immune system, genetic markers, and metabolism in people with endometriosis. The study looked at how these three areas interact to influence how the disease behaves. Specifically, they found that certain immune cells become exhausted or less active while others may promote an environment where the condition can persist.

These changes are influenced by epigenetic factors, which are chemical modifications to DNA and proteins. These processes can silence genes that would normally cause inflammation. Additionally, a low-oxygen environment in affected tissues may trigger metabolic shifts. This leads to a buildup of certain substances that act as signals for these genetic changes.

It is important to note that this research focuses on the underlying biological mechanisms rather than testing specific drugs or treatments. Because these findings are based on complex cellular processes, they do not provide immediate clinical results for patients. However, understanding these pathways may help doctors develop new ways to treat the condition in the future.

What this means for you:
Research shows that immune, genetic, and metabolic factors work together to influence how endometriosis develops.

Common questions

How does the immune system react to endometriosis?

The study found that certain immune cells show reduced activity and signs of exhaustion. At the same time, some cells that suppress the immune response may become more active. These changes, along with the presence of specific molecules, can help the condition avoid being stopped by the body's natural defenses.

What role does metabolism play in this condition?

A low-oxygen environment can cause a shift in how cells process energy. This leads to an increase in certain substances like lactate. These substances can act as signals that trigger changes in how genes are expressed, potentially influencing the progression of endometriosis.

How do genetic markers affect the disease?

The study describes epigenetic mechanisms, such as DNA methylation and histone modifications. These processes can silence certain genes while stabilizing others. These changes help create a stable environment for the condition to persist by affecting how immune cells behave.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
The survival of ectopic endometrial lesions in endometriosis critically depends on their ability to evade immune recognition and clearance by the host, a process known as immune evasion. Recent studies suggest that this process is not driven by a single factor but rather results from a multidimensional, interactive regulatory network involving immune dysregulation, epigenetic remodeling, and metabolic reprogramming. The pathophysiology of endometriosis is characterized by reduced cytotoxic activity and functional exhaustion of effector immune cells, along with excessive activation and expansion of immunosuppressive cells, affecting both innate and adaptive immunity. The overexpression of immune checkpoint molecules further impairs immunological clearance. DNA methylation, histone modifications, and non-coding RNAs contribute to immune cell tolerance by stabilizing repressive transcription programs and silencing pro-inflammatory genes. These epigenetic mechanisms maintain a sustained immunosuppressive state through direct regulation of immune-related genes and hormone-metabolizing enzymes. Additionally, the hypoxic environment of ectopic lesions stimulates glycolysis, leading to the accumulation of metabolites such as lactate. Beyond directly impairing immune cell function, these metabolites act as signaling molecules or cofactors for epigenetic enzymes, thereby influencing chromatin states and gene expression, thus mechanistically and functionally linking metabolism to epigenetics. This review aims to systematically unravel this multidimensional mechanism, elucidate its synergistic role in disease progression, and potentially pave the way for future combined therapeutic strategies targeting this complex pathway. Such approaches offer a novel and promising means to overcome immune evasion and clinical resistance in endometriosis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.